Reduced 1,25-dihydroxyvitamin D and 24,25-dihydroxyvitamin D in epileptic patients receiving chronic combined anticonvulsant therapy

Metabolic Bone Disease and Related Research - Tập 3 - Trang 17-22 - 1981
C.K. Christensen1,2,3, Bi Lund1,2,3, B.J. Lund1,2,3, O.H. Sørensen1,2,3, H.E. Nielsen1,2,3, L. Mosekilde1,2,3
1Department of Neurology and Department of Nuclear Medicine, Aarhus Municipal Hospital, Aarhus, Denmark
2Department of Orthopedic Surgery, Frederiksborg County Hospital, Hillerod, Denmark
3Department of Medicine E, Frederiksberg University Hospital, and Department of Medicine F, Herlev University Hospital, Copenhagen, Denmark

Tài liệu tham khảo

Bell, 1979, Effect of phenytoin on bone and vitamin D metabolism, Ann. Neurol., 5, 374, 10.1002/ana.410050411 Bergman, 1963, Two improved and simplified methods for the spectrofotometric determination of hydroxyproline, Anal. Chem., 35, 1961, 10.1021/ac60205a053 Bouillon, 1975, The effect of anticonvulsant therapy on serum levels of 25-hydroxyvitamin D, calcium and parathyroid hormone, J. Clin. Endocrinol., 41, 1130, 10.1210/jcem-41-6-1130 Boyle, 1971, Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol, 68, 2131 Caspary, 1972, Inhibition of intestinal calcium transport by diphenylhydantoin in rat duodenum, Naunyn Schmiedebergs, Arch. Pharmacol., 274, 146, 10.1007/BF00501849 Christiansen, 1973, Incidence of anticonvulsant osteomalacia and effect of vitamin D: Controlled therapeutic trial, Br. Med. J., 4, 695, 10.1136/bmj.4.5894.695 Corradino, 1976, Diphenylhydantoin: Direct inhibition of the vitamin D3-mediated calcium absorptive mechanism in organ cultured duodenum, Biochem. Pharmacol., 25, 863, 10.1016/0006-2952(76)90161-1 Eisman, 1979, Modulation of plasma 1,25-dihydroxyvitamin D in man by stimulation and suppressiontest, Lancet, 2, 931, 10.1016/S0140-6736(79)92624-2 Hahn, 1972, Phenobarbital-induced alterations in vitamin D metabolism, J. Clin. Invest., 51, 741, 10.1172/JCI106868 Hahn, 1972, Effect of chronic anticonvulsant therapy on serum 25-hydroxycholecalciferol levels in adults, New Engl. J. Med., 287, 900, 10.1056/NEJM197211022871803 Hughes, 1975, Regulation of serum 1α,25-dihydroxyvitamin D3 by calcium and phosphate in the rat, Science, 190, 578, 10.1126/science.1188357 Jones, 1975, High-pressure liquid chromatography: Separation of the metabolites of vitamin D2 and D3 on small-particle silica collumns, J. Lipid. Res., 16, 448, 10.1016/S0022-2275(20)34495-3 Jubiz, 1977, Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs, J. Clin. Endocrinol., 44, 617, 10.1210/jcem-44-4-617 Laitinen, 1975, Clinical applications of urinary hydroxyproline determination, Acta Med. Scand. Suppl., 577, 8 Lund, 1979, Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D in the Danish population, Scan. J. Clin. Lab. Invest., 39, 23, 10.3109/00365517909104935 Lund, 1979, Measurement of circulating 1,25-dihydroxyvitamin D in man. Changes in serum concentrations during treatment with 1α-hydroxycholecalciferol, Acta Endocrinol. (Copenh.), 91, 338, 10.1530/acta.0.0910338 Melsen, 1980, Some relations between photon-absorptionmetric and histomorphometric measurements of bone mass in the forearm, 45 Mosekilde, 1977, The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia, Acta Endocrinol. (Copenh.), 84, 559, 10.1530/acta.0.0840559 Mosekilde, 1979, Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy. Short term effect of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol, Acta Med. Scand., 205, 405, 10.1111/j.0954-6820.1979.tb06073.x Mosekilde, 1976, Anticonvulsant osteomalacia determined by quantitative analysis of bone changes: Population study and possible risk factors, Acta Med. Scand., 199, 349, 10.1111/j.0954-6820.1976.tb06747.x Mosekilde, 1980, Dynamic differences in trabecular bone remodelling between patients after jejunoileal bypass for obesity and epileptic patients receiving anticonvulsant therapy, Metab. Bone Dis. and Rel. Res., 2, 77, 10.1016/0221-8747(80)90001-6 Nielsen H.E., Mosekilde L., Mosekilde L., Melsen B., Christensen P., Olsen K.J. and Melsen F.: Relations of bone mineral content, ash-weight and bone mass: Implications for correction of bone mineral content for bone size. Clin. Orthop. and Rel. Res., in press. Norman, 1976, Biological effects of short-term phenobarbital treatment on the response to vitamin D and its metabolites in the chick, Biochem. Pharmacol., 25, 163, 10.1016/0006-2952(76)90285-9 Pedersen, 1973, Calcium in Human Serum: Biochemical and Clinical Aspects Richens, 1970, Disturbance of calcium metabolism by anticonvulsant drugs, Br. Med. J., 4, 73, 10.1136/bmj.4.5727.73 Shafer, 1975, Calcium and folic acid absorption in patients taking anticonvulsant drugs, J. Clin. Endocrinol., 41, 1125, 10.1210/jcem-41-6-1125 Silver, 1974, Effect of phenobarbitone treatment on vitamin D metabolism in mammals, Clin. Sci. Mol. Med., 46, 433 Taylor, 1978, The absence of 24,25-dihydroxycholecalciferol in anephric patients, Clin. Sci. Mol. Med., 55, 541 Weisman, 1979, Decreased serum 24,25-dihydroxyvitamin D concentrations in children receiving chronic anticonvulsant therapy, Br. Med. J., 2, 521, 10.1136/bmj.2.6189.521